ask="0.335"
ask_size="1000"
average_daily_volume="1673150"
bid="0.150"
bid_size="600"
book_value="0.168"
change="-0.003"
change_from_200_day_moving_average="-0.048"
change_from_50_day_moving_average="-0.010"
change_from_52_week_high="-0.817"
change_From_52_week_low="0.021"
change_in_percent="-1.045%"
close="0.303"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.204"
ebitda="-41.64M"
eps_estimate_current_year="-0.130"
eps_estimate_next_quarter="-0.030"
eps_estimate_next_year="-0.110"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.314"
high_52_weeks="1.120"
last_trade_date="1/25/2017"
last_trade_price="0.303"
last_trade_size="362"
last_trade_time="4:00pm"
low="0.300"
low_52_weeks="0.282"
market_capitalization="77.91M"
moving_average_200_day="0.351"
moving_average_50_day="0.313"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.250"
open="0.307"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-13.770%"
percent_change_from_50_day_moving_average="-3.204%"
percent_change_from_52_week_high="-72.946%"
percent_change_from_52_week_low="+7.447%"
previous_close="0.306"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.823"
price_per_sales="1.445"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.260"
stock_exchange="NCM"
symbol="PPHM"
volume="2005889"
weeks_range_52="0.282 - 1.120"
